SAM
ARRY

Stansberry Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Stansberry Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-59,922
Closed -$1M – 109
2018
Q2 		$1M Sell
59,922
-1,065
-2% -$16.9K 0.33% 56
2018
Q1 		$995K Buy
+60,987
New +$977K 0.49% 45

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Stansberry Asset Management's ARRY Position: Q3 2018 in Review

Stansberry Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2018, closing a stake of 59,922 shares — an estimated $1M sold.

Stansberry Asset Management first reported a position in ARRY in Q1 2018 and held it in 2 quarters. The position peaked at $1M in Q2 2018. 208 funds tracked by Wall St. Rank hold ARRY as of Q3 2018.

  • Stansberry Asset Management reported no remaining Array Biopharma Inc position as of Q3 2018 after selling out during the quarter.
  • Stansberry Asset Management sold 59,922 Array Biopharma Inc shares in Q3 2018, an estimated $1M.
  • Stansberry Asset Management first reported a position in Array Biopharma Inc in Q1 2018 and held it in 2 quarters.
  • Stansberry Asset Management's Array Biopharma Inc position peaked at $1M in Q2 2018.
  • 208 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2018.

Based on Stansberry Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.